These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

550 related items for PubMed ID: 1837999

  • 1. [The effects of the acute administration of atrial natriuretic peptide on the mechanisms regulating diuresis and natriuresis in the essential hypertension patient].
    Iannettone CM, Strazzulla G, Fabbri G, Piazza E, Valenza T, De Feo ML, Franchi F.
    Ann Ital Med Int; 1991; 6(3):273-83. PubMed ID: 1837999
    [Abstract] [Full Text] [Related]

  • 2. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
    Cusson JR, Hamet P, Gutkowska J, Kuchel O, Genest J, Cantin M, Larochelle P.
    J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
    [Abstract] [Full Text] [Related]

  • 3. Pressure-dependent, enhanced natriuretic response to low-dose, atrial natriuretic peptide infusion in essential hypertension.
    Eiskjaer H, Nielsen CB, Pedersen EB.
    J Intern Med; 1994 Dec; 236(6):665-74. PubMed ID: 7989902
    [Abstract] [Full Text] [Related]

  • 4. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM, Crozier IG, Espiner EA, Ikram H, Yandle TG, Kosoglou T, Rallings M, Frampton C.
    J Cardiovasc Pharmacol; 1992 Dec; 20(5):735-41. PubMed ID: 1280735
    [Abstract] [Full Text] [Related]

  • 5. Plasma concentration and renal effect of human atrial natriuretic peptide in nephrotic syndrome.
    Hisanaga S, Yamamoto Y, Kida O, Kato J, Fujimoto S, Tanaka K.
    Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):661-9. PubMed ID: 2529385
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Natriuretic action of ANP is blunted by ACE inhibition in humans.
    Wambach G, Schittenhelm U, Stimpel M, Bönner G, Kaufmann W.
    J Cardiovasc Pharmacol; 1989 May; 13(5):748-53. PubMed ID: 2472523
    [Abstract] [Full Text] [Related]

  • 8. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H, Nielsen CB, Pedersen EB.
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G, Lazzeri C, Pascale A, Sestini S, Bisi G, Sciagrà R, Vecchiarino S, Raggi VC, Barletta G, Laffi G, Gentilini P.
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [Abstract] [Full Text] [Related]

  • 10. Abnormal distal tubular sodium reabsorption during dopamine infusion in patients with essential hypertension evaluated by the lithium clearance methods.
    Nielsen CB, Pedersen EB.
    Clin Nephrol; 1997 May; 47(5):304-9. PubMed ID: 9181277
    [Abstract] [Full Text] [Related]

  • 11. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J, Mirzaian Y, Grabensee B.
    Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
    [Abstract] [Full Text] [Related]

  • 12. Atrial antipressor natriuretic peptide: release mechanisms and vascular action in man.
    Müller FB, Erne P, Raine AE, Bolli P, Linder L, Resink TJ, Cottier C, Bühler FR.
    J Hypertens Suppl; 1986 Jun; 4(2):S109-14. PubMed ID: 2941531
    [Abstract] [Full Text] [Related]

  • 13. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A, Ceolotto G, Sartori M, Maresca A, Baritono E, De Toni R, Paparella I, Calò L.
    J Nephrol; 2002 Jun; 15(5):489-96. PubMed ID: 12455714
    [Abstract] [Full Text] [Related]

  • 14. Blood levels and renal effects of atrial natriuretic peptide in normal man.
    Weidmann P, Hasler L, Gnädinger MP, Lang RE, Uehlinger DE, Shaw S, Rascher W, Reubi FC.
    J Clin Invest; 1986 Mar; 77(3):734-42. PubMed ID: 2936762
    [Abstract] [Full Text] [Related]

  • 15. Normal short-term renal response to acute volume expansion in heart transplant recipients: a role for atrial natriuretic peptide?
    Geny B, Charloux A, Schaefer A, Brandt C, Charpentier A, Kretz JG, Eisenmann B, Haberey P, Piquard F.
    J Heart Lung Transplant; 1998 Nov; 17(11):1081-8. PubMed ID: 9855447
    [Abstract] [Full Text] [Related]

  • 16. Effects of infusing alpha-atrial natriuretic peptide in primary hypertension during converting enzyme inhibition.
    Agabiti-Rosei E, Castellano M, Beschi M, Muiesan ML, Romanelli G, Rizzoni D, Muiesan G.
    J Cardiovasc Pharmacol; 1987 Nov; 10 Suppl 7():S151-3. PubMed ID: 2485053
    [Abstract] [Full Text] [Related]

  • 17. [The significance of atrial natriuretic polypeptide in the cause of essential hypertension].
    Mori K.
    Nihon Naibunpi Gakkai Zasshi; 1991 Jul 20; 67(7):796-810. PubMed ID: 1653713
    [Abstract] [Full Text] [Related]

  • 18. [The significance of cGMP and dopamine receptor on the natriuretic and hypotensive activities of synthetic atrial natriuretic polypeptide in essential hypertension].
    Mori K, Shigetomi S, Kohno H, Tosaki H, Kato K, Tanaka K, Haga H, Kin S, Fukuchi S.
    Nihon Naibunpi Gakkai Zasshi; 1990 Feb 20; 66(2):83-93. PubMed ID: 2158911
    [Abstract] [Full Text] [Related]

  • 19. The effect of human atrial natriuretic peptide on urinary sodium and urinary dopamine excretion in man.
    Struthers AD, Anderson JV, Causon RC, Christofides ND, Bloom SR.
    J Hypertens Suppl; 1985 Dec 20; 3(3):S315-7. PubMed ID: 2856726
    [Abstract] [Full Text] [Related]

  • 20. Saluretic and diuretic effects of antihypertensive nitrendipine monotherapy in man.
    Sambhi MP.
    Angiology; 1988 Jan 20; 39(1 Pt 2):106-12. PubMed ID: 3341609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.